The Pharmaceutical world and those involved with the manufacture of sterile products are anxiously looking out for the publication of the final approved revision of …
Annex 1 “Manufacture of Sterile Medicinal Products” was first published in 1971 and forms part of EudraLex Volume 4 [1], which interprets the basic principles …
The strategies used to create and maintain strong-pharmaceutical patent portfolios must evolve with developments in the pharmaceutical space. These developments include not just scientific advancements …
The challenge of ensuring healthcare sustainability, the rise in more targeted treatments, and a shift in emphasis to preventative interventions, not to mention the importance …
Companies must safeguard their mature portfolios while continuously innovating and developing new products. But in-house resources are stretched and often lack the broader knowledge needed …
The process of developing a revolutionary medical device from the proof-of-concept stage to the marketing stage is expensive and complicated. The creation of a new …
The application of high throughput screening techniques and computational chemistry has resulted in a marked shift in drug candidates with identified therapeutic potential, increasing the …
The Pharmaceutical world and those involved with the manufacture of sterile products are anxiously looking out for the publication of the final approved revision of EudraLex Annex 1 …
Annex 1 “Manufacture of Sterile Medicinal Products” was first published in 1971 and forms part of EudraLex Volume 4 [1], which interprets the basic principles of GMP as …
The strategies used to create and maintain strong-pharmaceutical patent portfolios must evolve with developments in the pharmaceutical space. These developments include not just scientific advancements but also requirements …
The challenge of ensuring healthcare sustainability, the rise in more targeted treatments, and a shift in emphasis to preventative interventions, not to mention the importance of patient centricity …
Companies must safeguard their mature portfolios while continuously innovating and developing new products. But in-house resources are stretched and often lack the broader knowledge needed to ensure best …
The process of developing a revolutionary medical device from the proof-of-concept stage to the marketing stage is expensive and complicated. The creation of a new product is a …
Aptar Pharma is the go-to drug delivery expert from formulation to the patient and a global leader in OINDP device design and technology. Pharmaceutical companies …
Thermo King, a brand of Trane Technologies, is the global leader in intelligent end-to-end temperature-controlled cold chain solutions. With over 80 years of history in …
Tower Cold Chain is a leading provider of temperature-controlled solutions to the global pharmaceutical, biotech and life-science industries. Working with businesses since 2007 to protect …
About Tive A leading provider of real-time supply chain visibility and insights, Tive ensures time- and temperature-sensitive shipments arrive on time and in full …
Intro Novo Nordisk Pharmatech A/S is a global and leading manufacturer of pharmaceutical ingredients for the pharmaceutical and biopharmaceutical industries. The company specialises in producing …
World market leader in the pharmaceutical packaging sector From a starting staff of four, Bausch+Ströbel has grown to an internationally operating group of companies with …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
